Renal Biomarkers Market: By Biomarker Type, By Diagnostic Technique, By End User, and Geography.  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Renal Biomarkers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Biomarker Type (Functional Biomarkers,Up-Regulated Proteins, Others ), By Diagnostic Technique (Particle enhanced turbidimetric immunoassay, Chemiluminescent enzyme immunoassay, Enzyme linked immunosorbent assay, Colorimetric assay, Liquid chromatography), By End User (Hospitals, Outpatient Clinics, Research Centers, Diagnostic Labs), and Region.  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Renal Biomarkers Market size was valued US$ 1042.1 billion by 2022 and expected to reach US$ 1454.08 billion by 2029, at a CAGR of 6.8% from 2023-2029. Renal diseases are one of the major cause of death in geriatric population. Renal biomarkers are measurable indicators used to screening, monitoring, and diagnosing the activity of renal diseases by determining their blood and urine levels. The biomarkers are administered into kidneys to determine the renal functions. The early diagnosis of renal diseases helps to take proper treatment before the irreversible damage of kidneys.

summary download arrow Download Free Sample

Renal Biomarkers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Renal Biomarkers Market Dynamics

Increase in the prevalence of renal diseases due to rise in hypertension and diabetes in elderly patients is a major factor fuel the renal biomarkers market. Rise in geriatric population, increase in the R&D for the development of novel renal biomarkers, and using of renal biomarkers in preclinical and clinical trials to determine the safety of new drugs are anticipated to propel the market. However, stringent regulatory scenario, lack of specificity and sensitivity in current renal biomarkers, and lack of favorable reimbursement policies are anticipated to impede the growth of renal biomarkers market.

Renal Biomarkers Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 1042.1 billion

Market Size in 2029

US$ 1454.08 billion

Market CAGR

6.8%

By Biomarker Type

  • Functional Biomarkers
  • Up-Regulated Proteins
  • Others

By Diagnostic Technique

  • Particle enhanced turbidimetric immunoassay
  • Chemiluminescent enzyme immunoassay
  • Enzyme linked immunosorbent assay
  • Colorimetric assay
  • Liquid chromatography

By End User

  • Hospitals
  • Outpatient Clinics
  • Research Centers
  • Diagnostic Labs

By Region

  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • North America

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

renal biomarkers market size valued US$ 1042.1 billion by 2022 and expected to reach US$ 1454.08 billion by 2029, at a CAGR of 6.8% during the forecast period 2023-2029

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Renal Biomarkers Market Introduction 
2.1.Global Renal Biomarkers Market  - Taxonomy
2.2.Global Renal Biomarkers Market  - Definitions
2.2.1.Biomarker Type
2.2.2.Diagnostic Technique
2.2.3.End User
2.2.4.Route of Administration
2.2.5.Region
3.Global Renal Biomarkers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Renal Biomarkers Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Renal Biomarkers Market  By Biomarker Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Functional Biomarkers
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Up-Regulated Proteins
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Renal Biomarkers Market  By Diagnostic Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Particle enhanced turbidimetric immunoassay
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Chemiluminescent enzyme immunoassay
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Enzyme linked immunosorbent assay
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Colorimetric assay
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Liquid chromatography
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Renal Biomarkers Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Outpatient Clinics
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research Centers
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Diagnostic Labs
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Renal Biomarkers Market  By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Injection
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Nasal Spray
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.Global Renal Biomarkers Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Renal Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Biomarker Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Functional Biomarkers
10.1.2.Up-Regulated Proteins
10.1.3.Others
10.2.  Diagnostic Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Particle enhanced turbidimetric immunoassay
10.2.2.Chemiluminescent enzyme immunoassay
10.2.3.Enzyme linked immunosorbent assay
10.2.4.Colorimetric assay
10.2.5.Liquid chromatography
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Outpatient Clinics
10.3.3.Research Centers
10.3.4.Diagnostic Labs
10.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Injection
10.4.2.Nasal Spray
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Renal Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Functional Biomarkers
11.1.2.Up-Regulated Proteins
11.1.3.Others
11.2.  Diagnostic Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Particle enhanced turbidimetric immunoassay
11.2.2.Chemiluminescent enzyme immunoassay
11.2.3.Enzyme linked immunosorbent assay
11.2.4.Colorimetric assay
11.2.5.Liquid chromatography
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Outpatient Clinics
11.3.3.Research Centers
11.3.4.Diagnostic Labs
11.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Injection
11.4.2.Nasal Spray
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Renal Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Functional Biomarkers
12.1.2.Up-Regulated Proteins
12.1.3.Others
12.2.  Diagnostic Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Particle enhanced turbidimetric immunoassay
12.2.2.Chemiluminescent enzyme immunoassay
12.2.3.Enzyme linked immunosorbent assay
12.2.4.Colorimetric assay
12.2.5.Liquid chromatography
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Outpatient Clinics
12.3.3.Research Centers
12.3.4.Diagnostic Labs
12.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Injection
12.4.2.Nasal Spray
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Renal Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Functional Biomarkers
13.1.2.Up-Regulated Proteins
13.1.3.Others
13.2.  Diagnostic Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Particle enhanced turbidimetric immunoassay
13.2.2.Chemiluminescent enzyme immunoassay
13.2.3.Enzyme linked immunosorbent assay
13.2.4.Colorimetric assay
13.2.5.Liquid chromatography
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Outpatient Clinics
13.3.3.Research Centers
13.3.4.Diagnostic Labs
13.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Injection
13.4.2.Nasal Spray
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Renal Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Biomarker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Functional Biomarkers
14.1.2.Up-Regulated Proteins
14.1.3.Others
14.2.  Diagnostic Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Particle enhanced turbidimetric immunoassay
14.2.2.Chemiluminescent enzyme immunoassay
14.2.3.Enzyme linked immunosorbent assay
14.2.4.Colorimetric assay
14.2.5.Liquid chromatography
14.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospitals
14.3.2.Outpatient Clinics
14.3.3.Research Centers
14.3.4.Diagnostic Labs
14.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Injection
14.4.2.Nasal Spray
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Merck Millipore (U.S)
15.2.2.Thermo Fisher Scientific Inc (U.S)
15.2.3.Hoffmann-La Roche Ag (Switzerland)
15.2.4.Abbott Molecular Inc (U.S)
15.2.5.Beckman Coulter Inc (U.S)
15.2.6.Astute Medical Inc (U.S)
15.2.7.Randox Laboratories Ltd (Ireland)
16. Research Methodology 
17. Appendix and Abbreviations 

 

Key Market Players

  • Merck Millipore (U.S)
  • Thermo Fisher Scientific Inc (U.S)
  • Hoffmann-La Roche Ag (Switzerland)
  • Abbott Molecular Inc (U.S)
  • Beckman Coulter Inc (U.S)
  • Astute Medical Inc (U.S)
  • Randox Laboratories Ltd (Ireland)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market